Terms: = Breast cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551
488 results:
1. Evolution of neoadjuvant therapy for breast cancer regimens over 12 years and pathologic response rates according to tumor subtypes and clinical stage: A single-center retrospective study.
Li Z; Wang Y
J Cancer Res Ther; 2024 Apr; 20(2):608-614. PubMed ID: 38687931
[TBL] [Abstract] [Full Text] [Related]
2. LIFU/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer.
Liu Y; Tang R; Cao Y; Wu N; Qin Q; Chen Y; Wei X; Ren J; Sun Y; Zhou H; Zhou Y; Li P
J Nanobiotechnology; 2024 Apr; 22(1):209. PubMed ID: 38664830
[TBL] [Abstract] [Full Text] [Related]
3. Bacteria-driven nanosonosensitizer delivery system for enhanced breast cancer treatment through sonodynamic therapy-induced immunogenic cell death.
Du M; Wang T; Peng W; Feng R; Goh M; Chen Z
J Nanobiotechnology; 2024 Apr; 22(1):167. PubMed ID: 38610042
[TBL] [Abstract] [Full Text] [Related]
4. The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer.
Yuan H; Liang Y; Hu S; Chen J; You J; Jiang J; Luo M; Zeng M
Medicine (Baltimore); 2024 Apr; 103(15):e37709. PubMed ID: 38608123
[TBL] [Abstract] [Full Text] [Related]
5. Zirconium-containing nanoscale coordination polymers for positron emission tomography and fluorescence-guided cargo delivery to triple-negative breast tumors.
Li YP; Pan ZW; Jiang YJ; Peng YY; Cai T; Hong H; Wang XF
Acta Biomater; 2024 Apr; 179():313-324. PubMed ID: 38490483
[TBL] [Abstract] [Full Text] [Related]
6. Application of fluorocarbon nanoparticles of
Zhi L; Cheng C; Jing L; Zhi-Ping P; Lu Y; Yan T; Zhi-Gang W; Guo-Bing Y
J Nanobiotechnology; 2024 Mar; 22(1):107. PubMed ID: 38475902
[TBL] [Abstract] [Full Text] [Related]
7. Detection and Management of Perioperative Hyperglycemia at a Tertiary cancer Center.
Taylor JS; Fellman BM; Raty S; Lasala J; Iniesta MD; Cain KE; Horner AA; Bruno M; Folloder JP; Knippel SL; Khanh V; Popovich S; Katz MHG; Best C; Thosani S
Ann Surg Oncol; 2024 May; 31(5):3017-3023. PubMed ID: 38347330
[TBL] [Abstract] [Full Text] [Related]
8. Modular Design Platform for Activatable Fluorescence Probes Targeting Carboxypeptidases Based on ProTide Chemistry.
Kuriki Y; Sogawa M; Komatsu T; Kawatani M; Fujioka H; Fujita K; Ueno T; Hanaoka K; Kojima R; Hino R; Ueo H; Ueo H; Kamiya M; Urano Y
J Am Chem Soc; 2024 Jan; 146(1):521-531. PubMed ID: 38110248
[TBL] [Abstract] [Full Text] [Related]
9. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
[TBL] [Abstract] [Full Text] [Related]
10. Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer.
Anabel Sinberger L; Zahavi T; Sonnenblick A; Salmon-Divon M
Sci Rep; 2023 Nov; 13(1):20911. PubMed ID: 38017109
[TBL] [Abstract] [Full Text] [Related]
11. Glutathione-responsive PROTAC for targeted degradation of ERα in breast cancer cells.
Zhou Z; Fan H; Yu D; Shi F; Li Q; Zhang Z; Wang X; Zhang X; Dong C; Sun H; Mi W
Bioorg Med Chem; 2023 Dec; 96():117526. PubMed ID: 38008041
[TBL] [Abstract] [Full Text] [Related]
12. Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC; Pepa M; Zaffaroni M; Vincini MG; Luraschi R; Vigorito S; Morra A; Dicuonzo S; Mazzola GC; Gerardi MA; Zerella MA; Cante D; Petrucci E; Borzì G; Marrocco M; Chieregato M; Iadanza L; Lobefalo F; Valenti M; Cavallo A; Russo S; Guernieri M; Malatesta T; Meaglia I; Liotta M; Palumbo I; Marcantonini M; Mezzenga E; Falivene S; Arrichiello C; Barbero MP; Ivaldi GB; Catalano G; Vidali C; Giannitto C; Ciabattoni A; Meattini I; Aristei C; Orecchia R; Cattani F; Jereczek-Fossa BA
Tumori; 2023 Dec; 109(6):570-575. PubMed ID: 37688419
[TBL] [Abstract] [Full Text] [Related]
13. Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative breast cancer by Activating the NF-κB Pathway.
Kuang W; Gu Q; Zhou Y; Xiao X; He D; Deng Q
Cell Biochem Biophys; 2023 Dec; 81(4):727-735. PubMed ID: 37658975
[TBL] [Abstract] [Full Text] [Related]
14. Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study.
Meric-Bernstam F; Calvo E; Lee KS; Moreno V; Park YH; Rha SY; Chalasani P; Zhong W; Zhou L; Pirie-Shepherd S; Leung ACF; Curigliano G
Mol Cancer Ther; 2023 Oct; 22(10):1191-1203. PubMed ID: 37420274
[TBL] [Abstract] [Full Text] [Related]
15. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract] [Full Text] [Related]
16. Spectroscopic studies on noncovalent binding of nicotinamide-modified BRCA1 (856-871) analogs to calf thymus DNA.
Pan B; Lv M; Du H; Zhao D; Lu K
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jun; 294():122531. PubMed ID: 36854231
[TBL] [Abstract] [Full Text] [Related]
17. [Questionnaire Survey of Treatment Strategies for Gastric cancer with Peritoneal Dissemination in Yamaguchi Prefecture].
Nakashima C; Iida M; Takeda S; Harada E; Miyazaki K; Kondo J; Kawaoka T; Oka I; Watanabe M; Takahashi T; Ioka T; Hamano K; Nagano H
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1616-1618. PubMed ID: 36733153
[TBL] [Abstract] [Full Text] [Related]
18. Synthesis, Solid State Structure, and Cytotoxic Activity of a Complex Dimer of Yttrium with Anthranilic Acid against cancer Cells.
Zidan ASA; Ibrahim ABM; Aly AAM; Mosbah HK; Mayer P; Saber SH
Biol Trace Elem Res; 2023 Oct; 201(10):4688-4696. PubMed ID: 36602747
[TBL] [Abstract] [Full Text] [Related]
19. Genomic characteristics of two breast malignant phyllodes tumors during pregnancy and lactation identified through whole-exome sequencing.
Lei T; Shen M; Deng X; Shi Y; Peng Y; Wang H; Chen T
Orphanet J Rare Dis; 2022 Oct; 17(1):382. PubMed ID: 36271373
[TBL] [Abstract] [Full Text] [Related]
20. Lysine-Directed Site-Selective Bioconjugation for the Creation of Radioimmunoconjugates.
Sarrett SM; Rodriguez C; Rymarczyk G; Hosny MM; Keinänen O; Delaney S; Thau S; Krantz BA; Zeglis BM
Bioconjug Chem; 2022 Sep; 33(9):1750-1760. PubMed ID: 35946495
[TBL] [Abstract] [Full Text] [Related]
[Next]
